Feature|Videos|April 10, 2025
Fueling Innovation Through Client Centricity
Author(s)Rentschler Biopharma
Christiane Bardroff, Chief Operating Officer and Patrick Meyer Global Head of Business Development—both at Rentschler Biopharma SE—share their insights into the company’s client-centric approach.
Rentschler Biopharma's client-first approach, major investments in US and German sites, and the launch of Rentschler Development Services are positioning the company to best offer flexible, tailored solutions. Watch this video to learn more about:
- How Rentschler Biopharma’s client-centric approach drives innovation in biologics development and manufacturing.
- The capabilities at Rentschler’s state-of-the-art biologics facility in Milford, MA.
- Customized services and solutions available at the Milford, MA site.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
